Move the needle in fusion with our foundational, proven solution
MagnetOs Granules

MagnetOs™ Granules is the original form of our advanced bone graft based on the submicron needle-shaped NeedleGrip™ surface technology. It remains the foundation of the MagnetOs formulations and is the driver of our mechanism of action for bone generation in the extremities.†1-3
Evidence isn’t optional for Kuros. We are committed to generating high-quality evidence, enabling our team to discover, develop and deliver innovative biologic technologies with one goal in mind: To give surgeons the confidence to make evidence-based decisions for their patients.
These novel innovations have revealed a powered mechanism of action for bone growth, offering tremendous promise for predictable fusions and traumatic reconstructions of the extremity.
Handling
Packaged in granule form without any carrier, MagnetOs Granules lends itself to growing bone in amorphous and contained or semi-contained voids.4
Proven Foundation
MagnetOs Granules are the basis for all MagnetOs formulations and have been CE-marked since 2017. This foundational technology is supported by an unprecedented blend of scientific, preclinical, and clinical studies through our global research program, Project Fusion.
Harnessing the immune system
MagnetOs is capable of polarizing macrophages from the M1 pro-inflammatory to the M2 pro-healing phenotype, which is known to influence bone growth through secretion of proteins such as BMP-2. Pre-clinical studies have demonstrated the osteoinductive potential of MagnetOs without added cells or growth factors.*†‡1-3
These features combine to make MagnetOs an active player in providing predictable joint fusions and traumatic reconstructions of the extremity.
Equivalent to autograft
In fact, MagnetOs Granules as a standalone bone graft reached higher fusion rates than the gold standard of autograft. This is based on results of an observer blinded, randomized, controlled, intrapatient, multi-center clinical trial of instrumented posterolateral fusions of the spine, as assessed by fine-cut CT scans at one year follow-up.5
The MagnetOs Granules technology is also proven to be equivalent to autograft for spinal fusions in multiple pre-clinical models.*†‡#1-3
Product code Volume (CC) Granule size (mm)
703-021 10 1 – 2
703-026 20 2 – 4
Want to learn more about MagnetOs Granules?
Book your own appointment with one of our scientific experts.
* In large animal models.
† Results from in vitro or in vivo laboratory testing may not be predictive of clinical experience in humans. For important safety and intended use information please visit kurosbio.com/eifu.
‡ MagnetOs is not cleared by the FDA or TGA as an osteoinductive bone graft.
# MagnetOs has been proven to generate more predictable fusions that two commercially available alternatives in an ovine model of posterolateral fusion.
1. Van Dijk, et al. eCM.2021;41:756-73.
2. Van Dijk, et al. J Immunol Regen Med. 2023;19:100070.
3. Duan, et al. eCM. 2019;37:60-73.
4. Instructions for Use (IFU) MagnetOs Granules (CE).
5. Stempels, et al. Spine. 2024;49(19):1323-1331.
MAT-0240